In Canada, products containing BLIS K12 can now claim to “promote oral health."
Photo © iStockphoto.com/Kurhan
Patented probiotic strain BLIS K12 has now been approved for an oral-health claim in Canada. Products containing BLIS K12 can now claim to “promote oral health,” because BLIS K12, also known as Streptococcus salivarius strain K12, has been shown to help re-colonize the oral cavity with healthy bacteria.
BLIS K12 can also bear the following claims:
BLIS K12 partners, distributor Stratum Nutrition (St. Charles, MO) and New Zealand–based BLIS Technologies, announced the news. “Stratum was pleased to be able to use our regulatory expertise in North America to open up the Canadian market for BLIS K12, and we expect the strong efficacy claims that were approve to really resonate with Canadian consumers," said Kevin Ruff, PhD, director of scientific and regulatory affairs for Stratum, in a press release.
In addition to the health claim, Health Canada has granted BLIS K12 a natural product number.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.